Camp4 Therapeutics Corporation

NasdaqGM:CAMP Stock Report

Market Cap: US$234.2m

Camp4 Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:CAMP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Mar 26SellUS$1,366,441Enavate SciencesCompany225,358US$6.69
23 Dec 25SellUS$4,219,903Enavate SciencesCompany658,442US$6.87
11 Sep 25BuyUS$24,999Richard YoungIndividual15,151US$1.65
11 Sep 25BuyUS$9,999Joshua Mandel-BrehmIndividual6,060US$1.65
11 Sep 25BuyUS$1,999,999Polaris Venture Partners, Inc.Company1,307,189US$1.53
11 Sep 25BuyUS$9,999Kelly GoldIndividual6,060US$1.65
11 Sep 25BuyUS$9,999Yuri MaricichIndividual6,060US$1.65
11 Sep 25BuyUS$4,499,9995AM Venture Management, LLCCompany2,941,176US$1.53
11 Sep 25BuyUS$4,499,9995AM Venture Management, LLCCompany2,941,176US$1.53

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CAMP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders761,5371.45%
Private Companies3,099,2315.9%
Hedge Funds7,519,15914.3%
VC/PE Firms14,047,91026.8%
Institutions27,082,73751.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 157.6%.

Top Shareholders

Top 25 shareholders own 98.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
12.2%
Janus Henderson Group plc
6,307,636US$28.4m0%0.01%
11.3%
5AM Venture Management, LLC
5,869,091US$26.5m0%7.91%
9.5%
FMR LLC
4,933,432US$22.2m0.31%no data
9.41%
Coastlands Capital LP
4,886,722US$22.0m0%no data
8.18%
Vivo Capital, LLC
4,246,568US$19.2m10.1%1.67%
7.57%
Polaris Venture Partners, Inc.
3,932,251US$17.7m0%32.53%
5.07%
Balyasny Asset Management L.P.
2,632,437US$11.9m8.02%0.02%
4.31%
Northpond Ventures, LLC
2,238,244US$10.1m0%25.14%
4.22%
Enavate Sciences
2,190,920US$9.9m-27.8%no data
4.09%
Andreessen Horowitz LLC
2,125,339US$9.6m0%0.61%
3.78%
Adage Capital Management, L.P.
1,960,784US$8.8m-10.1%0.01%
3.74%
Trails Edge Capital Partners, LP
1,939,563US$8.7m-2.24%1.9%
2.96%
Vanguard Capital Management, LLC
1,534,768US$6.9m0%no data
2.68%
Stonepine Capital Management LLC
1,389,622US$6.3m507%3.17%
2.45%
HarbourVest Partners, LLC
1,271,948US$5.7m0%4.29%
1.75%
Kaiser Permanente Group Trust
908,311US$4.1m0%no data
1.26%
Silverarc Capital Management, LLC
653,594US$2.9m0%0.34%
0.88%
BlackRock, Inc.
456,371US$2.1m17%no data
0.74%
Geode Capital Management, LLC
382,821US$1.7m13.8%no data
0.65%
Crestline Investors Inc.
339,521US$1.5m0%0.04%
0.65%
Susquehanna International Group, LLP
336,047US$1.5m0%no data
0.54%
Joshua Mandel-Brehm
278,417US$1.3m0%no data
0.38%
Vanguard Fiduciary Trust Company
195,013US$879.5k13.3%no data
0.33%
Richard Young
170,010US$766.7k0%no data
0.28%
State Street Global Advisors, Inc.
146,900US$662.5k270%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/26 10:42
End of Day Share Price 2026/05/22 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Camp4 Therapeutics Corporation is covered by 6 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Steven SeedhouseCantor Fitzgerald & Co.
Anupam RamaJ.P. Morgan
Eric JosephJ.P. Morgan